CME
Expires
Claim CME Credit

The Role of Atrial Shunts in the Treatment of HFpEF

 

 

 

ACCME credit This educational program focuses on exploring the role of atrial shunts in managing heart failure with preserved ejection fraction (HFpEF). It delves into various aspects of interatrial shunting and its potential in addressing residual risk in HFpEF. The program is designed to provide insights from leading experts in the field, covering the long-term impact on right heart function, evaluating relevant clinical endpoints, and comparing different shunting techniques and devices.

CME ACCREDITATION AND DESIGNATION

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™ for physicians. Physicians can claim credit commensurate with the extent of their participation in the activity.

Participants will earn MOC points equivalent to the number of CME credits claimed for the activity. Successful completion of this CME activity enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM)Maintenance of Certification (MOC) program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting American Board of Internal Medicine (ABIM) MOC points.

ACTIVITY EVALUATION

Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.

To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Thaifa Smith at tsmith@crf.org.

Upon completion of this CME program, participants should be able to:

• Describe the current landscape of residual risk and unmet therapeutic needs in patients with heart failure, regardless of ejection fraction.
• Explain the role of advanced imaging techniques in assessing right heart function and flow patterns relevant to heart failure.
• Analyze the potential long-term impact of atrial shunting on right heart size and function.
• Correlate hemodynamic parameters with measures of functional capacity and quality of life in heart failure patients.
• Discuss the clinical implications of these insights for evaluating and managing heart failure patients, particularly those considered for atrial shunting.

 

This program is designed for a multidisciplinary audience:

• Heart failure specialists (fellows, nurses, physicians, physician assistants, and research coordinators)
• Cardiac imaging specialists
• Cardiac and vascular surgeons
• Clinical cardiologists
• Fellows in interventional cardiovascular medicine and related fields
• Industry professionals
• Interventional cardiologists
• Medical device experts
• Nurse practitioners
• Other health care professionals
• Physician assistants
• Research scientists

 

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships within the last 24 months with ineligible companies.

Accredited providers are required to provide this information to learners before the start of an activity. Discussion of off-label product usage during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty
Full Name		 Disclosure of Relevant
Financial Relationship		 Nature of Financial Relationships Individual's Role(s)
in Activity		 Mitigation Methods
Dean J. Kereiakes, MD Yes Consultant Fee/Honoraria/Speaker's Bureau - Sino Medical Sciences Techologies; Orchestra Biomed Inc; Shockwave; Elixir Medical Corp; CeleCor; Foldax; JC Medical Inc. Equity/Stock(s)/Options - Ablative Solutions, Inc Industry-Funded Research - Edwards Lifesciences Planner/Faculty Recusal from controlling aspects of planning and content with which there is a financial relationship Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines
William A. Gray, MD Yes Grant Support/Research Contract - Conformal; Edwards Lifesciences Consultant Fee/Honoraria/Speaker's Bureau - Shockwave; W.L. Gore & Associates; Medtronic; Philips; Contego Medical; ReValve Medical Industry Salary/Salary Support/Employee (full time or part time) - Boston Scientific Corporation Faculty Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines
JoAnn Lindenfeld, MD Yes Grant Support/Research Contract - Volumetrix Consultant Fee/Honoraria/Speaker’s Bureau - Alleviant Medical; CVRx; Edwards Lifesciences; Impluse Dynamics; V-Wave; Abiomed; Boston Scientific Corporation; Cardiac Dimensions; Merck/Schering Plough; Kestra Faculty Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines
Muhammad, Kamran Yes Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Abbott; Medtronic Faculty Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines)
Pankaj Garg, MD Yes Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Edwards Lifesciences; Anteris Faculty Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines
Ryan J. Tedford, MD Yes Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Edwards Lifesciences; Merck/Schering Plough; Gradient; Boston Scientific Corporation; Aria CV Travel to meeting - Abiomed Consultant Fee/Honoraria/Speaker's Bureau - Acorai; Adona; Endotronix, Inc.; Fauna Bio; morphic therapeutics; Medtronic; Imbria; Pulmovant; Restore medical; Tempus AI; United Therapeutics Equity/Stock(s)/Options - Aria CV; Acorai travel to meeting - CVRx Planner/Faculty Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines

CME Reviewer(s) and Associate Course Directors(s):

Gary S. Mintz, MD — Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Abbott; SpectraWave; Philips; Panovision

Grzegorz L. Kaluza, MD, PhD — Grant Support/Research Contract - Terumo Medical Corporation; Bristol-Myers Squibb; Edwards Lifesciences; Reflow Medical; Shape Memory Medical; Occlutech; Lungpacer; InnovHeart; Ancora Heart; Dura Biotech; Mitria; InQB8; Ethicon; R3 Vascular; Puzzle Medical; VivaSure; Magenta Medical; Acotec Scientific; Microbot; Philips; Zoll; Cook Medical; Medtronic; ReValve Medical; Orchestra Biomed; MicroVention; Retriever Medical; Siemens Healthineers; Trisol Medical; Abbott; Bayliss Medical; Dropshot Therapeutics; Abiomed; Autonomix; UltraVet; Meacor; JensCare; Mitre Medical; TheraHeart; Tonic Medical; M2SP LLC; MagPad LLC; Relief Cardiovascular; Cresilon; Synchron; PECA Labs; Solaris; VST Bio; Cagent Vascular; SirTex; Bonaparte Medical; SmartWave; Xenter; Versa Vascular; Genesis Tissue; Eleuso

Thaifa Smith – has no financial relationship(s) with ineligible companies to disclose.

Yullee Lai – has no financial relationship(s) with ineligible companies to disclose.

CRF identifies relevant financial relationships and mitigates them before the activity begins. The CME associate course directors documented that all relevant financial relationships have been mitigated as of 2/27/2026.

 

The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without the influence from commercial supporters.

This enduring webcast was supported by Edwards Lifesciences.

 

 

We Recommend

Heart Failure